Drugs / CD7-CART01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06064903 | Apr 2024 → Sep 2028 expected | T lymphoblastic leukemia/lymphoma | Bambino Gesù Hospital and Research Institute | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD7-CART01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06064903 ↗ |
| Modality | Cell therapy | “CD7-directed chimeric antigen receptor T-cells” NCT06064903 ↗ |
| Route | Intravenous | “A single IV infusion of CD7-CART01 on Day 0” NCT06064903 ↗ |
| Target | CD7 | “CD7-directed chimeric antigen receptor T-cells” NCT06064903 ↗ |